Innova Captab (INNOVACAP) | Stock Overview & Key Data
Innova Captab Performance Comparison
Stock Range
Today's Range
Low: ₹898.50
High: ₹909.00
on August 19, 2025
52 Week Range
Low: ₹648.00
High: ₹1,260.00
on August 29, 2024
on January 8, 2025
All-Time High: ₹1,260.00 on January 6, 2025
Explore how other Indian stocks compare to their 52-week ranges: View IN Market 52-Week Insights
Key Statistics
Market Cap
INR51.8B
EPS
22.64
P/E Ratio (TTM)
40.00
Forward P/E
21.77
P/B Ratio
5.40
PEG Ratio
7.63
Div. Yield
N/A
ROE
13.37%
Beta
N/A
Debt to Equity
35.24
Financial Highlights
Profitability
Gross Margin
37.21%
Operating Margin
11.68%
Profit Margin
9.98%
Returns and Earnings
Return on Assets (TTM)
8.12%
Return on Equity (TTM)
13.37%
EBITDA
INR2.1B
Net Income (TTM)
INR1.3B
Growth
Revenue (TTM)
Revenue Per Share (TTM)
INR227.34
Quarterly Revenue Growth (YoY)
19.50%
Quarterly Earnings Growth (YoY)
5.20%
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Innova Captab INNOVACAP | 51.83B Mid-cap | 0.49% | 0.47% | -1.96% | 17.30% | -18.38% | 30.82% | 67.25% | 67.25% |
| Sun Pharmaceutical SUNPHARMA | 3.94T Large-cap | 1.51% | -3.60% | -5.64% | -4.05% | -13.61% | -8.06% | 85.50% | 193.78% |
| Divi's Laboratories DIVISLAB | 1.63T Large-cap | 2.88% | -8.42% | -6.31% | 5.56% | 1.51% | 26.95% | 71.83% | 88.35% |
| Alembic APLLTD | 188.36B Mid-cap | 2.34% | -5.79% | -5.54% | 20.07% | -7.37% | -11.76% | 49.26% | -1.74% |
| Neuland Laboratories NEULANDLAB | 170.36B Mid-cap | 1.77% | -5.13% | 20.63% | 22.71% | -5.33% | 10.93% | 1,037.72% | 1,307.24% |
| Jubilant Pharmova JUBLPHARMA | 167.27B Mid-cap | -4.50% | -14.47% | 9.75% | 5.10% | -2.43% | 16.21% | 212.62% | 72.32% |
Ownership & Short Interest
Insider Ownership
72.55%
Institutional Ownership
18.51%
Shares Short
N/A
Short Ratio
N/A
Short % of Shares Outstanding
N/A
Average 10-Day Volume
42K
Average 90-Day Volume
45K
Innova Captab Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in Innova Captab would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is INNOVACAP's 52-week high and low?
- In the last 52 weeks, Innova Captab reached a high of ₹1,260.00 (on January 8, 2025) and a low of ₹648.00 (on August 29, 2024).
- What is the market cap and P/E ratio for INNOVACAP?
- Curious about Innova Captab's size and valuation? Its market capitalization stands at 51.83B. When it comes to valuation, the P/E ratio (trailing twelve months) is 40.00, and the forward P/E (looking ahead) is 21.77.
- Does INNOVACAP pay dividends? If so, what's the yield?
- As for dividends, Innova Captab isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Innova Captab's main competitors or similar companies to consider before investing?
When looking at Innova Captab, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Sun Pharmaceutical
SUNPHARMA3.94T Healthcare Drug Manufacturers - Specialty & Generic -8.06% 85.50% Divi's Laboratories
DIVISLAB1.63T Healthcare Drug Manufacturers - Specialty & Generic 26.95% 71.83% Alembic
APLLTD188.36B Healthcare Drug Manufacturers - Specialty & Generic -11.76% 49.26% Neuland Laboratories
NEULANDLAB170.36B Healthcare Drug Manufacturers - Specialty & Generic 10.93% 1,037.72% Jubilant Pharmova
JUBLPHARMA167.27B Healthcare Drug Manufacturers - Specialty & Generic 16.21% 212.62% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Innova Captab Ltd.? (e.g., ROE, Debt/Equity)
- To get a sense of Innova Captab's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 13.37%, the Debt to Equity ratio from the most recent quarter is 35.24, and its Gross Profit Margin stands at 37.21%.
- What is the recent revenue and earnings growth for INNOVACAP?
- Looking at Innova Captab's growth, its revenue over the trailing twelve months (TTM) was INR13B. Compared to the same quarter last year (YoY), quarterly revenue grew by 19.50%, and quarterly earnings saw a YoY growth of 5.20%.
- How much of INNOVACAP stock is held by insiders and institutions?
- Wondering who owns Innova Captab stock? Company insiders (like executives and directors) hold about 72.55% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 18.51%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.